yeah, joey, you are correct, not speaking for everyone, but a lot of bio investors have the dream of striking it big in a fast fashion, like a lot of lottery players, and actually the folks who went to Calif. and Alaska during the gold rush. I can vividly remember waking up one morning and seeing the news when HGSI got approval, it was my first big winner, then more recently when ARNA got adcom approval, then fda approval. I must admit it is a great feeling, and to a lesser extent when AIS went from 2.60 to 5.50, a double, in a matter of weeks. As for the CLSN crash, yes, that goes with the bio territory.For every DNDN, there is 2 or 3 or 4 CLSN. There has been lots of new posters here in recent weeks, maybe some from CLSN, but the fact is, ATRS is not going to be the typical all or nothing bio tech, as they are not a one shot wonder, no pun intended, and the next move up will probably be more of a substained on over a period of many months and years.